Literature DB >> 9210755

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.

T U Woo1, J L Miller, D A Lewis.   

Abstract

OBJECTIVE: The purpose of this study was to test the hypothesis that abnormalities in the parvalbumin-containing subclass of local circuit neurons contribute to altered gamma-aminobutyric acid (GABA) neurotransmission in the prefrontal cortex of schizophrenic subjects.
METHOD: Profile counts and somal size measures were made of parvalbumin-immunoreactive neurons in areas 9, 46, and 17 from 15 matched pairs of schizophrenic and normal comparison subjects.
RESULTS: No differences in relative density, laminar distribution, or somal size of labeled neurons were found in any region.
CONCLUSIONS: These findings suggest that altered GABA neurotransmission in schizophrenia is due to either abnormalities in other sub-populations of prefrontal cortical GABA neurons or abnormalities in the parvalbumin-containing subclass that could not be detected in the present study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210755     DOI: 10.1176/ajp.154.7.1013

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  70 in total

Review 1.  Hippocampal neurons in schizophrenia.

Authors:  S Heckers; C Konradi
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

3.  Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.

Authors:  Monica Beneyto; Andrew Abbott; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2010-09-15       Impact factor: 5.357

Review 4.  Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.

Authors:  Ana D Stan; David A Lewis
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

Review 5.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

6.  Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

7.  Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes.

Authors:  Kazuyuki Fujihara; Hideki Miwa; Toshikazu Kakizaki; Ryosuke Kaneko; Masahiko Mikuni; Chiyoko Tanahira; Nobuaki Tamamaki; Yuchio Yanagawa
Journal:  Neuropsychopharmacology       Date:  2015-04-23       Impact factor: 7.853

Review 8.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

Review 9.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

10.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.